1-89933291-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001134479.2(LRRC8D):c.223G>A(p.Val75Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000149 in 1,614,108 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001134479.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC8D | NM_001134479.2 | c.223G>A | p.Val75Ile | missense_variant | 3/3 | ENST00000337338.9 | NP_001127951.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC8D | ENST00000337338.9 | c.223G>A | p.Val75Ile | missense_variant | 3/3 | 2 | NM_001134479.2 | ENSP00000338887 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000223 AC: 56AN: 250978Hom.: 1 AF XY: 0.000243 AC XY: 33AN XY: 135640
GnomAD4 exome AF: 0.000150 AC: 219AN: 1461876Hom.: 1 Cov.: 33 AF XY: 0.000164 AC XY: 119AN XY: 727242
GnomAD4 genome AF: 0.000138 AC: 21AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74432
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | The c.223G>A (p.V75I) alteration is located in exon 3 (coding exon 1) of the LRRC8D gene. This alteration results from a G to A substitution at nucleotide position 223, causing the valine (V) at amino acid position 75 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at